These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15927107)

  • 1. [Fibrinogen. An old hemostatic protein with a new function: non-invasive marker of subclinical atherosclerosis].
    Páramo JA; Rodríguez JA; Orbe J
    Med Clin (Barc); 2005 May; 124(20):790-4. PubMed ID: 15927107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen: its role in the hemostatic regulation in atherosclerosis.
    Eber B; Schumacher M
    Semin Thromb Hemost; 1993; 19(2):104-7. PubMed ID: 8356454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
    Cortellaro M; Boschetti C; Cofrancesco E; Zanussi C; Catalano M; de Gaetano G; Gabrielli L; Lombardi B; Specchia G; Tavazzi L
    Arterioscler Thromb; 1992 Sep; 12(9):1063-70. PubMed ID: 1525121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients.
    Solomon C; Cadamuro J; Ziegler B; Schöchl H; Varvenne M; Sørensen B; Hochleitner G; Rahe-Meyer N
    Transfusion; 2011 Aug; 51(8):1695-706. PubMed ID: 21352237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype.
    Hirano K; Takashima S; Dougu N; Taguchi Y; Nukui T; Konishi H; Toyoda S; Kitajima I; Tanaka K
    J Stroke Cerebrovasc Dis; 2012 Jul; 21(5):404-10. PubMed ID: 22516429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque.
    Rabbani LE; Loscalzo J
    Atherosclerosis; 1994 Jan; 105(1):1-7. PubMed ID: 8155083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease.
    Kannel WB
    Lipids; 2005 Dec; 40(12):1215-20. PubMed ID: 16477805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of haemostatic factors, arteriosclerosis and cardiovascular disease.
    Haverkate F
    Vascul Pharmacol; 2002 Aug; 39(3):109-12. PubMed ID: 12616975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients.
    Cortellaro M; Boschetti C; Cofrancesco E; Zanussi C; Catalano M; de Gaetano G; Gabrielli L; Lombardi B; Specchia G; Tavazzi L
    Atherosclerosis; 1991 Oct; 90(2-3):109-18. PubMed ID: 1759983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study.
    Knuiman MW; Folsom AR; Chambless LE; Liao D; Wu KK
    Neuroepidemiology; 2001 May; 20(2):96-104. PubMed ID: 11359076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin as a factor in atherogenesis.
    Smith EB; Thompson WD
    Thromb Res; 1994 Jan; 73(1):1-19. PubMed ID: 8178309
    [No Abstract]   [Full Text] [Related]  

  • 14. Etiology and management of hypofibrinogenemia in trauma.
    Nathwani R; Proumen A; Blaine KP
    Curr Opin Anaesthesiol; 2023 Jun; 36(3):382-387. PubMed ID: 36994749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic risk factors for atherothrombotic disease: an epidemiologic view.
    Folsom AR
    Thromb Haemost; 2001 Jul; 86(1):366-73. PubMed ID: 11487026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic biomarkers in cancer progression.
    Falanga A; Marchetti M
    Thromb Res; 2018 Apr; 164 Suppl 1():S54-S61. PubMed ID: 29703485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants.
    Smith FB; Rumley A; Lee AJ; Leng GC; Fowkes FG; Lowe GD
    Br J Haematol; 1998 Mar; 100(4):758-63. PubMed ID: 9531345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Folsom AR; Rosamond WD; Shahar E; Cooper LS; Aleksic N; Nieto FJ; Rasmussen ML; Wu KK
    Circulation; 1999 Aug; 100(7):736-42. PubMed ID: 10449696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers.
    MacCallum PK
    Proc Am Thorac Soc; 2005; 2(1):34-43. PubMed ID: 16113467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.